Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

[Recommendation for use of belimumab for systemic lupus erythematosus]. Z Rheumatol 2013; 72: 462–7 CrossRef MEDLINE 33. Henderson L, Masson P, Craig JC, et al.: Treatment for lupus nephritis.

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system ... diagnostic evaluation, and treatment. In ...

Lupus, also known as systemic lupus erythematosus (SLE), is an autoimmune disease that ... as well as both conventional and natural approaches to treatment. Lupus is a chronic autoimmune disease that ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

Systemic lupus erythematosus (SLE) is the most common form of lupus ... A study of racial/ethnic differences in treatment preferences among lupus patients. Rheumatology (Oxford) 2012;51(9):1697-706.

Systemic lupus erythematosus is a potentially fatal autoimmune ... owing to a lack of reliable biomarkers, and current treatments rely on clinical experience. This Review covers recent clinical ...

SLE: Systemic lupus erythematosus. Symptoms of systemic lupus ... Damage resulting from the disease and its treatment must be minimized. Long-term morbidity and mortality must be avoided.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with ...